Tourettes Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025


#8265

Transparency Market Research

$ 5795

Tourette’s syndrome is a severe and rare neurological disorder characterized by stereotyped, repetitive, involuntary movements, and vocalizations. It usually affects children aged between six years and 17 years. A tic is a sudden, no rhythmic motor movement, repetitive or vocalization involving discrete muscle groups. Generally, tics are categorized into simple or complex tics. Simple tics are defined as sudden, brief, repetitive movements of muscles. Others include eye blinking, facial grimacing, head or shoulder jerking, shoulder shrugging, and repetitive throat-clearing. Complex tics are coordinated patterns of movements associated with several muscle groups. Facial grimacing, sniffing or touching objects, bending, twisting, and jumping can be termed as complex tics. Usually, the first symptoms of tics occur in head and neck area and progress to trunk and extremities muscles. Tourette’s syndrome is associated with other additional neurobehavioral problems such as inattention, impulsivity (attention deficit hyperactivity disorder-ADHD), problems with reading and writing, and obsessive-compulsive symptoms.

Health care professionals diagnose Tourette’s syndrome based on motor and vocal tics for at least a year. Other neurological or psychiatric conditions including compulsive behaviors in obsessive-compulsive disorder and stereotypic behaviors in autism also help to diagnose Tourette’s syndrome. Neuroimaging studies including computerized tomography (CT), magnetic resonance imaging (MRI), electroencephalogram (EEG) scans, and certain blood tests help to diagnose Tourette’s syndrome. Neuroleptics is one of the most recommended medications for the treatment of the syndrome. Haloperidol and pimozide are popular medicine for Tourette’s syndrome. Other medications such as clonidine and guanfacine can also be useful to reduce tic severity. Increase in research and development as well as health care infrastructure globally drive the Tourette’s syndrome treatment market. Rise in medical costs restrain the market in developing countries.

The global Tourette’s syndrome treatment market can be segmented based on medical treatment and region. In terms of medical treatment, the market can be categorized into behavior, psychotherapy, and medication. Medicines including fluphenazine, haloperidol (Haldol), and pimozide (Orap) can help control tics in Tourette’s syndrome. Non-tic symptoms can be treated with anti-obsessionals such as selective serotonin reuptake inhibitors, or SSRIs or ADHD medication including dextroamphetamine, atomoxetine, and methylphenidate. Depending on the severity, combination drug is also recommended by health care professional for Tourette’s syndrome.

Geographically, the global Tourette’s syndrome treatment market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. These regions can be further segmented into countries and medical treatment. North America is the leading market for Tourette’s syndrome treatment. In terms of revenue, the U.S. holds a major share of the market in North America. The market in Europe is expanding rapidly due to rise in prevalence of Tourette’s syndrome in the region. The market in Asia Pacific and Latin America is projected to expand significantly in the near future due to high annual incidence of Tourette’s syndrome. Developing economies such as China and India are anticipated to contribute to the growth of the market in Asia Pacific between 2017 and 2025 due to better health care infrastructure, economic growth, increase in the number of insurance payers, growth of the private health care sector, and increase in awareness among people. Brazil and Mexico dominate the Tourette’s syndrome market in Latin America. South Africa, Turkey, and other developing countries in Middle East & Africa are the major markets for Tourette’s syndrome treatment in this region.

Key players operating in the global Tourette’s syndrome treatment market are Neurocrine Biosciences, Inc., Novartis AG, Otsuka Pharmaceutical Co., Ltd., Teva Pharmaceuticals USA, Inc., Apotex, Inc., Janssen Pharmaceuticals, Inc., Zydus Pharmaceuticals USA, Inc., Eli Lilly and Company, and Torrent Pharmaceuticals Limited.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.